CAS 1257044-99-7
:Venclexta Impurity 3
Description:
Venclexta Impurity 3, identified by its CAS number 1257044-99-7, is a chemical compound associated with the synthesis of the drug venetoclax, which is used in the treatment of certain types of cancer, particularly chronic lymphocytic leukemia (CLL). While specific details about the impurity may not be widely published, impurities in pharmaceutical compounds often arise during the synthesis process and can affect the purity, efficacy, and safety of the final product. Generally, impurities like Venclexta Impurity 3 may exhibit similar structural characteristics to the parent compound but may differ in functional groups or stereochemistry. The presence of such impurities is typically monitored and controlled during drug development to ensure compliance with regulatory standards. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify impurities in pharmaceutical formulations. Understanding the characteristics of impurities is crucial for ensuring the quality and safety of pharmaceutical products.
Formula:C39H38Cl2N6O6S
Synonyms:- N-[(4-Chloro-3-nitrophenyl)sulfonyl]-4-[4-[[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl]piperazin-1-yl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide
- Venclexta Impurity 3
- Benzamide, N-[(4-chloro-3-nitrophenyl)sulfonyl]-4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
